Interaction between mitochondria and microbiota modulating cellular metabolism in inflammatory bowel disease

Misa Hirose, Priyadharshini Sekar, Mariam Wed Abdelaziz Eladham, Mohammad T. Albataineh, Mohamed Rahmani, Saleh Mohamed Ibrahim*

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Inflammatory bowel disease (IBD) is a prototypic complex disease in the gastrointestinal tract that has been increasing in incidence and prevalence in recent decades. Although the precise pathophysiology of IBD remains to be elucidated, a large body of evidence suggests the critical roles of mitochondria and intestinal microbiota in the pathogenesis of IBD. In addition to their contributions to the disease, both mitochondria and gut microbes may interact with each other and modulate disease-causing cell activities. Therefore, we hypothesize that dissecting this unique interaction may help to identify novel pathways involved in IBD, which will further contribute to discovering new therapeutic approaches to the disease. As poorly treated IBD significantly affects the quality of life of patients and is associated with risks and complications, successful treatment is crucial. In this review, we stratify previously reported experimental and clinical observations of the role of mitochondria and intestinal microbiota in IBD. Additionally, we review the intercommunication between mitochondria, and the intestinal microbiome in patients with IBD is reviewed along with the potential mediators for these interactions. We specifically focus on their roles in cellular metabolism in intestinal epithelial cells and immune cells. To this end, we propose a potential therapeutic intervention strategy for IBD.

OriginalspracheEnglisch
ZeitschriftJournal of Molecular Medicine
Jahrgang101
Ausgabenummer12
Seiten (von - bis)1513-1526
Seitenumfang14
ISSN0946-2716
DOIs
PublikationsstatusVeröffentlicht - 12.2023

Zitieren